Marktgröße und Marktanteil von Impfstoffen gegen Vogelgrippe bis 2025 – 2031
Avian influenza vaccines Market Report Analysis
Avian influenza vaccines Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million

Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Boehringer Ingelheim GmbH
- CAVAC
- CEVA
- DHN
- Elanco
- FATRO S.p.A.
- Harbin Veterinary Research Institute (HVRI)
- Merck Animal Health (a subsidiary of Merck & Co. Inc.)
- Merial (a Sanofi Company)
Regional Overview

- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Market Segmentation

- inaktivierte Impfstoffe
- rekombinante Lebendimpfstoffe
- Kombinationsimpfstoffe

- H5-Stamm
- H7-Stamm
- H9-Stamm

- Huhn
- Ente und Gans
- andere.

- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika